Cargando…

Real-Life Use of Tocilizumab in the Treatment of Severe COVID-19 Pneumonia

INTRODUCTION: Coronavirus disease 2019 (COVID-19) can progress to severe respiratory compromise and lead to mortality due to induction of cytokine storm. Tocilizumab (TCZ) is approved by the FDA for the treatment of cytokine release syndrome (CRS). This study aims to analyze the outcomes among patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alex, Ruth, Gulam, Shabaz Mohiuddin, Kumar, Kiran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203205/ https://www.ncbi.nlm.nih.gov/pubmed/35721667 http://dx.doi.org/10.1155/2022/7060466

Ejemplares similares

Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?
por: Shankar, Pathiyil Ravi, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia
por: Mourad, Jean-Jacques, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Lipworth, Brian J, et al.
Publicado: (2020)

Tocilizumab for severe COVID-19 pneumonia
por: Piano, Salvatore, et al.
Publicado: (2020)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Successful treatment of severe COVID-19 pneumonia and hyperinflammatory syndrome with tocilizumab
por: Gentile, Giorgio, et al.
Publicado: (2021)

Tocilizumab for severe COVID-19 pneumonia – Authors' reply
por: Guaraldi, Giovanni, et al.
Publicado: (2020)

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
por: Rosas, Ivan O., et al.
Publicado: (2021)

Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia: A retrospective cohort study
por: Russo, Gianluca, et al.
Publicado: (2021)

Comparative efficacy of azithromycin versus clarithromycin in combination with beta-lactams to treat community-acquired pneumonia in hospitalized patients: a systematic review
por: Al-Salloum, Jumana, et al.
Publicado: (2021)

Scholarly Pathway: Understanding, Planning, and Competency Mapping in Pharmacy Education
por: Gillani, Syed Wasif, et al.
Publicado: (2020)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases
por: Chochoł-Labun, Joanna, et al.
Publicado: (2021)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
por: van Kraaij, Tom DA, et al.
Publicado: (2020)

Tocilizumab and PMX-DHP have efficacy for severe COVID-19 pneumonia
por: Shinomiya, Shohei, et al.
Publicado: (2021)

High-flow nasal oxygen in severe COVID-19 pneumonia and tocilizumab
por: Mandal, M., et al.
Publicado: (2022)

Tocilizumab is recommended for the treatment of severe COVID-19
por: Zhou, Yonggang, et al.
Publicado: (2020)

Tocilizumab in severe COVID-19
por: Lucio Liberato, Nicola, et al.
Publicado: (2020)

Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 Patients
por: Sarhan, Rania M., et al.
Publicado: (2022)

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
por: Salama, Carlos, et al.
Publicado: (2020)

Tocilizumab improves survival in patients with persistent hypoxia in severe COVID-19 pneumonia
por: Gokhale, Yojana, et al.
Publicado: (2020)

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis
por: Roumier, Mathilde, et al.
Publicado: (2020)

A single-center experience in use of tocilizumab in COVID-19 pneumonia in India
por: Joshi, Aditya, et al.
Publicado: (2021)

LUNG ABSCESSES IN A PATIENT TREATED WITH TOCILIZUMAB FOR COVID-19 PNEUMONIA COMPLICATED BY SEVERE HYPOXEMIC RESPIRATORY FAILURE
por: Kashin, Maxim, et al.
Publicado: (2020)

1146. Real-World Experience Highlighting Tocilizumab Use in the Treatment of COVID-19
por: Maguire, Christina, et al.
Publicado: (2022)

Effective treatment of severe COVID-19 patients with tocilizumab
por: Xu, Xiaoling, et al.
Publicado: (2020)

Tocilizumab, an Exploratory Treatment for Severe COVID-19 Patients
por: Wang, Yong, et al.
Publicado: (2022)

Outcomes of treatment of severe COVID-19 pneumonia with tocilizumab: a report of two cases from Tunisia
por: Azaiz, Mouna Ben, et al.
Publicado: (2021)

Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19
por: Widysanto, Allen, et al.
Publicado: (2021)

Rapid radiological improvement of COVID-19 pneumonia after treatment with tocilizumab
por: Comel, Andrea Claudio, et al.
Publicado: (2020)

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia
por: Warner, Adam, et al.
Publicado: (2021)

Prevalence of Hospital-Acquired Pneumonia Among Patients With Severe to Critical COVID-19 Pneumonia Given Tocilizumab
por: Adre, Lorenzo Abednego B, et al.
Publicado: (2023)

Tocilizumab in severe COVID-19 pneumonia: A retrospective case-control study from eastern India
por: Mouli, Tatikonda Chandra, et al.
Publicado: (2023)

PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021)

Successful high flow nasal cannula therapy for severe COVID-19 pneumonia is associated with tocilizumab use
por: Ouissa, R., et al.
Publicado: (2022)

Testing the efficacy of tocilizumab in patients with COVID-19 pneumonia
por: Agirbasli, Mehmet, et al.
Publicado: (2021)

Use of tocilizumab in COVID-19 pneumonia hospitalized patients. Cohort study
por: Anci, Cynthia, et al.
Publicado: (2023)

Don’t close the book on tocilizumab for the treatment of severe COVID-19 pneumonia–the jury is still out: The Kuwait experience
por: Al-Shamali, Yousef, et al.
Publicado: (2021)

Outcomes associated with tocilizumab with or without corticosteroid versus dexamethasone for treatment of patients with severe to critical COVID-19 pneumonia
por: AlQahtani, Hajar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_drusl59hglmnvq38lqs0kb6m16